Clinically utilized kappa-opioid receptor agonist nalfurafine combined with low-dose naltrexone prevents alcohol relapse-like drinking in male and female mice. [electronic resource]
Producer: 20201029Description: 146410 p. digitalISSN:- 1872-6240
- Alcohol Drinking -- drug therapy
- Alcoholism -- drug therapy
- Analgesics, Opioid -- pharmacology
- Animals
- Drinking -- drug effects
- Ethanol -- pharmacology
- Female
- Male
- Mice
- Mice, Inbred C57BL
- Morphinans -- metabolism
- Naltrexone -- metabolism
- Narcotic Antagonists -- pharmacology
- Receptors, Opioid, kappa -- agonists
- Receptors, Opioid, mu -- metabolism
- Recurrence
- Secondary Prevention -- methods
- Spiro Compounds -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.